Characteristics and outcomes of cerebral venous thrombosis associated with COVID-19.
Adrian ScutelnicAnita van de MunckhofAngel T MiraclinSanjith AaronSajid HameedMohammad WasayOxana GrosuKatarzyna KrzywickaMayte Sánchez van KammenErik LindgrenTiago MoreiraRoberto AcamporaAlberto NegroTheodoros KarapanayiotidesShadi YaghiAnna RevertElisa Cuadrado GodiaSebastian Garcia-MadronaPaolino La SpinaFrancesco GrilloFabrizio GiammelloThanh N NguyenMohamad AbdalkaderAlina ButureMaria Sofia CotelliNicolas RaposoGeorgios K TsivgoulisPaolo CandelaresiAntonio CiacciarelliJoshua MbrohTatiana BatenkovaPasquale ScoppettuoloMarialuisa ZeddeRosario PascarellaKateryna AntonenkoEspen Saxhaug KristoffersenJohanna A Kremer HovingaKatarina JoodDiana Aguiar de SousaSven PoliTurgut TatlisumakJukka PutaalaJonathan M CoutinhoJosé M FerroMarcel ArnoldMirjam R HeldnerPublished in: European stroke journal (2024)
In contrast to previous studies, the in-hospital mortality rate and functional outcomes during follow-up did not differ between COVID-CVT patients and the pre-COVID-19 controls.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- respiratory syndrome coronavirus
- magnetic resonance
- prognostic factors
- peritoneal dialysis
- type diabetes
- subarachnoid hemorrhage
- magnetic resonance imaging
- adipose tissue
- metabolic syndrome
- insulin resistance